Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.

Unproven, dangerous cancer medicine got go-ahead from FDA

John Fauber | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Walking the beaches around ...

FDA likely to approve new recombinant hemophilia drug

John Gever | 
A recombinant fusion drug combining the Factor VIII protein with an FC antibody peptide to extend its lifetime in circulation ...

Genotyping lung cancer linked to better survival

Crystal Phend | 
Genetic testing for personalized treatment of lung cancer was associated with improved survival, likely due to getting targeted kinase inhibitors ...

NIH prepares for surge in whole-genome sequencing

David Pittman | 
The medical community needs a plan for handling the fast-growing knowledge about the health risks identified through whole-genome sequencing, said ...

Epigenetics may tie diabetes to dementia

John Gever | 
Altered genomic regulation of expression of key synaptic proteins may be responsible for the increased risk of dementia seen in ...

Gene linked to improved survival of pulmonary fibrosis

Crystal Phend | 
The following is an edited excerpt. New research, released in the New England Journal of Medicine, suggests that a common ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists